Influenza virion envelope

The influenza virion envelope is a host-derived lipid bilayer that serves as the outer protective shell of the influenza virus, playing a central role in the viral life cycle and pathogenesis (Wikipedia, 2024). It incorporates three essential transmembrane proteins: hemagglutinin (HA), neuraminidase (NA), and the matrix protein 2 (M2) ion channel, all of which are critical for infection (NIH, 2023). Hemagglutinin facilitates the initial attachment to host cell sialic acid receptors and subsequent membrane fusion, while neuraminidase enables the release of progeny virions by cleaving sialic acid residues (StatPearls, 2023). The M2 protein functions as a proton channel that acidifies the viral core, allowing for the release of the viral genome into the host cytoplasm (PubMed, 2021). Because these proteins are exposed on the viral surface, the envelope is the primary target for both the host immune response and pharmacological interventions. Current drugs target these components through various mechanisms, such as neuraminidase inhibitors (e.g., oseltamivir) and M2 ion channel blockers (e.g., amantadine), although the high mutation rate of the virus frequently leads to the emergence of drug-resistant strains (CDC, 2024).

Other names

Influenza viral envelopeInfluenza lipid bilayerInfluenza viral membraneInfluenza surface glycoprotein complex

Inhibition of neuraminidase to prevent viral release, blockade of M2 ion channels to prevent viral uncoating, and inhibition of hemagglutinin to prevent viral-host membrane fusion.